Irlanda - anglès - HPRA (Health Products Regulatory Authority)

galderma (uk) ltd - amorolfine hydrochloride - medicated nail lacquer - 5 %w/v - amorolfine

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

galderma international - amorolfine - medicated nail lacquer - 5 percent weight/volume - other antifungals for topical use; amorolfine

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

galderma (uk) ltd - amorolfine hydrochloride - medicated nail lacquer - 50mg/1ml

Índia - anglès - Central Drugs Standard Control Organization

twilight lit. - tab - 10

Índia - anglès - Central Drugs Standard Control Organization

twilight lit. - gel

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

galderma benelux b.v. - amorolfine hydrochloride 64 mg/g - eq. amorolfine 50 mg/g - medicated nail lacquer - 5 % - amorolfine hydrochloride 64 mg/g - amorolfine

República de Sud-àfrica - anglès - South African Health Products Regulatory Authority (SAHPRA)

mylan pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains darunavir ethanolate 400,0 mg ritonavir 50,0 mg

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - ondansetron 4mg;   - orodispersible tablet - 4 mg - active: ondansetron 4mg   excipient: aspartame colloidal silicon dioxide crospovidone microcrystalline cellulose and guar gum (avicel ce15) strawberry flavour (gurana powder) isopropyl alcohol magnesium stearate mannitol microcrystalline cellulose purified water sodium laurilsulfate starch - ondansetron-drla tablets and ondansetron odt-drla tablets are indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron-drla tablets and ondansetron odt-drla tablets are also indicated for the prevention of post-operative nausea and vomiting.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - ondansetron 8mg;   - orodispersible tablet - 8 mg - active: ondansetron 8mg   excipient: aspartame colloidal silicon dioxide crospovidone microcrystalline cellulose and guar gum (avicel phce15) strawberry flavour (gurana powder) isopropyl alcohol magnesium stearate mannitol microcrystalline cellulose purified water sodium laurilsulfate starch - ondansetron-drla tablets and ondansetron odt-drla tablets are indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron-drla tablets and ondansetron odt-drla tablets are also indicated for the prevention of post-operative nausea and vomiting.